Меню
Набор скоро начнётся NCT07722169

Telerehabilitation in Alzheimer's Disease

Без фазы С лечением Alzheimer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Online cognitive telerehabilitation, VRRS tablet.
Кому может быть актуально
Состояния в реестре: Alzheimer. Базовые параметры: 50 лет — 90 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Home-based Virtual Reality Cognitive Training as an add-on to Telerehabilitation in Alzheimer's Disease: Validation of a Protocol to Slow Down Cognitive Decline and Reduce Caregivers' Burden

Обзор

Telemedicine has developed rapidly during the COVID-19 pandemic and is now integrated into the clinical practice of many hospitals. Telemedicine offers many advantages, and even after the end of the pandemic, many patients still choose to undergo healthcare visits remotely. However, the rapid expansion of telemedicine may be associated with the risk of providing patients with unvalidated and uncontrolled telehealth solutions, potentially negatively impacting their health. In this study, the researchers aim to investigate the effectiveness of remote cognitive training in patients with mild-to-moderate Alzheimer's disease (AD) using tablets equipped with virtual reality-based cognitive exercises. The investigators also aim to evaluate the impact of online supervision of cognitive training by a neuropsychologist and to compare the costs and burden of home-based versus hospital-based cognitive training in patients with AD. This project will define the optimal modalities for cognitive telerehabilitation to ensure validated protocols for the continuity of care in AD.

Подробное описание

This project aims to use new technologies and telemedicine to ensure continuity of care and slow cognitive decline in patients with Alzheimer's disease (AD). The investigators also aim to reduce caregiver burden and healthcare costs for the national healthcare system.

The investigators hypothesize that patients provided with a VRRS tablet and undergoing autonomous cognitive training as an adjunct to cognitive telerehabilitation will achieve better cognitive outcomes than patients who do not receive a VRRS tablet.

The investigators also hypothesize that patients receiving both forms of cognitive training-autonomous training using the VRRS tablet combined with online cognitive telerehabilitation supervised by a professional neuropsychologist-will show greater improvements in cognitive function than patients who do not receive online cognitive telerehabilitation.

This is a prospective, interventional, randomized, single-blind, monocentric clinical study.

Study population: 48 patients with AD (MMSE score 18-24) and one caregiver for each patient (48 caregivers in total).

To minimize potential bias, the neuropsychologist responsible for patient and caregiver assessments will be blinded to treatment allocation.

Patients will be randomized in a 1:1:1 ratio to one of the following treatment groups:

* Intervention Group 1:\*\* 16 patients provided with a VRRS tablet to perform autonomous home-based cognitive training (5 days per week), in addition to online cognitive telerehabilitation sessions supervised by a neuropsychologist at San Raffaele Hospital twice weekly. * Intervention Group 2:\*\* 16 patients provided with a VRRS tablet to perform autonomous home-based cognitive training (5 days per week), without neuropsychologist-supervised cognitive telerehabilitation. * Comparator Group 3:\*\* 16 patients receiving online cognitive telerehabilitation sessions supervised by a neuropsychologist twice weekly. These patients will not receive a VRRS tablet for home use.

No interim analysis is planned.

Study design:

Each group will undergo a 3-month intervention according to the following schedule.

Group 1:

Autonomous home-based cognitive training using the VRRS tablet for 1 hour per day, 5 days per week.

Remote cognitive telerehabilitation sessions supervised by a neuropsychologist twice weekly.

Group 2:

Autonomous home-based cognitive training using the VRRS tablet for 1 hour per day, 5 days per week.

No cognitive telerehabilitation sessions.

Group 3:

Remote cognitive telerehabilitation sessions supervised by a neuropsychologist twice weekly.

No VRRS tablet and no additional autonomous home-based cognitive training.

\- Study visits:

Patients and caregivers will attend the following visits:

1. Enrolment. 2. Screening (Day 1) and treatment initiation. 3. Post-treatment assessment (after 3 months of treatment). 4. Follow-up assessment (3 months after completion of treatment).

* Methods of data collection

The following data will be collected:

* patients' neuropsychological performance; * electroencephalographic (EEG) activity; * caregivers' mental health and caregiver burden; * system usability; * costs associated with telerehabilitation and cognitive training. * Assessment of patients' neuropsychological performance:

Patients will undergo a comprehensive neuropsychological assessment at three time points: baseline, after the 3-month treatment period, and at the 3-month follow-up.

The assessment battery will include:

* Montreal Cognitive Assessment (MoCA) (primary outcome): a screening tool for cognitive impairment providing a total score and six domain-specific index scores (Memory, Executive Function, Attention, Language, Visuospatial Ability, and Orientation). Total scores range from 0 to 30, with scores ≥26 generally considered normal. * Mini-Mental State Examination (MMSE). * Quality of Life in Alzheimer's Disease (QoL-AD). * Geriatric Depression Scale (GDS). * Attention Matrices. * Raven's Progressive Matrices. * Token Test. * Semantic Fluency Test. * Phonemic Fluency Test. * Naming Test. * Word-Picture Naming Test. * Digit Span Test (forward and backward). * Corsi Block-Tapping Test. * Rey Complex Figure Test. * Trail Making Test. * EEG assessment:

Five minutes of resting-state EEG will be recorded using 32-channel EEG caps before and after the intervention to perform time-frequency analyses.

* Assessment of caregivers' mental health and burden: * Beck Depression Inventory-II (BDI-II). * Zarit Burden Interview.

Assessment of system usability:

System Usability Scale (SUS). Usability will be evaluated in terms of effectiveness, efficiency, and user satisfaction.

\- Assessment of the costs of telerehabilitation and cognitive training:

The following cost components will be analysed:

* healthcare professional costs (neuropsychologist); * outpatient clinic costs; * telemedicine equipment costs for both patients and the hospital; * patients' travel costs; * cognitive training equipment costs; * caregiver burden; * system usability.

Any future research involving the collected data will require prior approval from the Ethics Committee (EC).

Вмешательства

  • Устройство Online cognitive telerehabilitation
    Online sessions of cognitive telerehabilitation, twice a week, supervised by a neuropsychologist based at the San Raffaele hospital.
  • Устройство VRRS tablet
    Patients equipped with VRRS tablets to undergo autonomous home-based cognitive training (5 days a week).

Первичные конечные точки

  • Montreal Cognitive Assessment (MoCA) [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
Вторичные конечные точки (12)
  • Electroencephalographic (EEG) activity [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Caregivers' mental status [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Caregivers' burden [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • System usability [Срок оценки: At the end of the 3-month rehabilitation period.]
  • Telerehabilitation's costs [Срок оценки: At 3 months follow-up.]
  • Mini Mental State Examination (MMSE) [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Quality of Live in Alzheimer's Disease (QoL-AD) [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Geriatric Depression Scale (GDS) [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Attention matrices [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Raven's Progressive Matrices (RPM) [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Token test [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]
  • Semantic and phonemic fluency [Срок оценки: (1) before telerehabilitation, (2) at the end of the 3-month rehabilitation period, and (3) 3 months following the end of treatment.]

Критерии участия

Inclusion criteria for patients with Alzheimer's disease (AD):

  • Age between 50 and 90 years.
  • Diagnosis of Alzheimer's disease according to established diagnostic criteria.
  • Mini-Mental State Examination (MMSE) score between 18 and 24.
  • Stable pharmacological treatment for at least 3 months before enrolment.
  • Ability and willingness to provide written informed consent.

Inclusion criteria for caregivers:

  • Age ≥18 years.
  • Availability to assist the patient throughout the study.
  • Ability and willingness to provide written informed consent.

Exclusion criteria for patients with Alzheimer's disease (AD):

  • Refusal or inability to provide written informed consent.
  • History of psychiatric disorders.
  • Significant cerebrovascular disease.
  • Severe visual or hearing impairment that could interfere with study procedures.
  • Psychosis.
  • Major depressive disorder.
  • Alcohol or substance abuse.
  • Use of psychotropic medications that may interfere with neuropsychological assessment or study treatment.
  • Concurrent participation in another interventional pharmacological clinical trial.
  • Any contraindication to undergoing EEG recording.

Exclusion criteria for caregivers:

  • Refusal or inability to provide written informed consent.
  • History of psychiatric disorders.
  • Major depressive disorder.
  • Alcohol or substance abuse.
  • Use of psychotropic medications that may interfere with neuropsychological assessment.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Публикации

  • Gatica-Rojas V, Mendez-Rebolledo G. Virtual reality interface devices in the reorganization of neural networks in the brain of patients with neurological diseases. Neural Regen Res. 2014 Apr 15;9(8):888-96. doi: 10.4103/1673-5374.131612. PMID 25206907
  • Yang JG, Thapa N, Park HJ, Bae S, Park KW, Park JH, Park H. Virtual Reality and Exercise Training Enhance Brain, Cognitive, and Physical Health in Older Adults with Mild Cognitive Impairment. Int J Environ Res Public Health. 2022 Oct 15;19(20):13300. doi: 10.3390/ijerph192013300. PMID 36293881
  • Laver KE, George S, Thomas S, Deutsch JE, Crotty M. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev. 2015 Feb 12;2015(2):CD008349. doi: 10.1002/14651858.CD008349.pub3. PMID 25927099
  • Buschert V, Bokde AL, Hampel H. Cognitive intervention in Alzheimer disease. Nat Rev Neurol. 2010 Sep;6(9):508-17. doi: 10.1038/nrneurol.2010.113. Epub 2010 Aug 17. PMID 20717104
  • Emedoli D, Houdayer E, Della Rosa PA, Zito A, Brugliera L, Cimino P, Padul JD, Tettamanti A, Iannaccone S, Alemanno F. Continuity of care for patients with dementia during COVID-19 pandemic: flexibility and integration between in-person and remote visits. Front Public Health. 2024 Jan 8;11:1301949. doi: 10.3389/fpubh.2023.1301949. eCollection 2023. PMID 38259745
  • Emedoli D, Alemanno F, Houdayer E, Brugliera L, Iannaccone S, Tettamanti A. Mobile application tool for remote rehabilitation after discharge from coronavirus disease-19 rehabilitation unit. Healthc Technol Lett. 2022 Aug 8;9(4-5):70-76. doi: 10.1049/htl2.12033. eCollection 2022 Aug-Oct. PMID 36225346
  • Elbaz S, Cinalioglu K, Sekhon K, Gruber J, Rigas C, Bodenstein K, Naghi K, Lavin P, Greenway KT, Vahia I, Rej S, Sekhon H. A Systematic Review of Telemedicine for Older Adults With Dementia During COVID-19: An Alternative to In-person Health Services? Front Neurol. 2021 Dec 14;12:761965. doi: 10.3389/fneur.2021.761965. eCollection 2021. PMID 34970210
  • Grabher BJ. Effects of Alzheimer Disease on Patients and Their Family. J Nucl Med Technol. 2018 Dec;46(4):335-340. doi: 10.2967/jnmt.118.218057. Epub 2018 Aug 23. PMID 30139888

Идентификаторы

NCT: NCT07722169 · RF-2024-12380126 VRTAD

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗